Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

References

• Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998; 82: 2N–9N
   PubMed Web of Science ®Google Scholar
• Lip GYH. Does atrial fibrillation confer a hypercoagulable state?. Lancet. 1994; 346: 1313–4
   Google Scholar
• Lip GYH, Lip PL, Zarifis J, Watson RD, Bareford D, Lowe GDO, et al. Fibrin D-dimer and β-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Circulation. 1996; 94: 425–31
   PubMed Web of Science ®Google Scholar
• Roldán V, Marín F, Blann AD, García A, Marco P, Sogorb F, et al. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J. 2003; 24: 1373–80
   PubMed Web of Science ®Google Scholar
• Marín F, Roldán V, Tello A, Lip GY. Genetic polymorphisms and thromboembolic risk in atrial fibrillation. J Thromb Thrombolysis. 2004; 18: 151–2
   PubMed Web of Science ®Google Scholar
• Pengo V, Filippi B, Biasiolo A, Pegoraro C, Noventa F, Iliceto S. Association of the G20210A mutation in the factor II gene with systemic embolism in nonvalvular atrial fibrillation. Am J Cardiol. 2002; 90: 545–7
   PubMed Web of Science ®Google Scholar
• Poli D, Antonucci E, Cecchi E, Betti I, Valdré L, Mugnaini C, et al. Thrombophilic mutations in high-risk atrial fibrillation patients: high prevalence of prothrombin gene G20210A polymorphism and lack of correlation with thromboembolism. Thromb Haemost. 2003; 90: 1158–62
   PubMed Web of Science ®Google Scholar
• Go AS, Reed GL, Hylek EM, Phillips KA, Liu L, Henault LE, et al. Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. J Thromb Thrombolysis. 2003; 15: 41–6
   PubMed Web of Science ®Google Scholar
• Carter AM, Catto AJ, Grant PJ. Association of the α-Fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation. 1999; 99: 2423–6
   PubMed Web of Science ®Google Scholar
• Feinberg WM, Pearce LA, Hart RG, Cushman M, Cornell ES, Lip GY, et al. Markers of thrombin and platelet activity in patients with atrial fibrillation. Correlation with stroke among 1531 participants in the Stroke Prevention in Atrial Fibrillation III Study. Stroke. 1999; 30: 2547–53
   PubMed Web of Science ®Google Scholar
• Marín F, Corral J, Roldán V, González-Conejero R, del Rey ML, Sogorb F, et al. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation. J Mol Cell Cardiol. 2004; 37: 699–704
   PubMed Web of Science ®Google Scholar
• Sacchi E, Tagliabue L, Scoglio R, Baroncini C, Coppola R, Bernardi F, et al. Plasma factor VII levels are influenced by a polymorphism in the promoter region of the FVII gene. Blood Coagul Fibrinolysis. 1996; 72: 114–7
   Google Scholar
• Bernardi F, Arcieri P, Bertina RM, Chiarotti F, Corral J, Pinotti M, et al. Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations. Arterioscl Thromb Vasc Biol. 1997; 17: 2548–53
   PubMed Web of Science ®Google Scholar
• Roldán V, Corral J, Marín F, Vicente V, González-Conejero R. Effect of factor VII -323 Del/Ins polymorphism on diurnal variation of FVIIc and INR in steady anticoagulated patients with atrial fibrillation. J Thromb Haemost. 2004; 2: 2264–5
   Google Scholar
• Iacoviello L, Di Castelnuovo A, De Knijff P, D'Orazio A, Di Bitondo R, Di Castelnuovo A, et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. New Eng J Med. 1998; 338: 79–84
   PubMed Web of Science ®Google Scholar
• Corral J, Iniesta JA, González-Conejero R, Villalón M, Vicente V. Polymorphism of clotting factors modify the risk for primary intracraneal hemorrhage. Blood. 2001; 97: 2979–82
   PubMedGoogle Scholar
• Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994; 369: 64–7
   PubMed Web of Science ®Google Scholar
• Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88: 3698–703
   PubMed Web of Science ®Google Scholar
• Corral J, González-Conejero R, Iniesta JA, Rivera J, Martínez C, Vicente V. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica. 2000; 85: 293–7
   PubMed Web of Science ®Google Scholar
• Iniesta JA, González-Conejero R, Piqueras C, Vicente V, Corral J. Platelet GP IIIa polymorphism HPA-1 (PlA) protects against subarachnoid hemorrhage. Stroke. 2004; 35: 2282–6
   Google Scholar
• Corral J, González-Conejero R, Rivera J, Ortuño F, Aparicio P, Vicente V. Role of the 807 C/T polymorphism of the alpha2 gene in platelet GP Ia collagen receptor expression and function-effect in thromboembolic diseases. Thromb Haemost. 1999; 81: 951–6
   PubMed Web of Science ®Google Scholar
• Roldán V, González-Conejero R, Marín F, Pineda J, Vicente V, Corral J. Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction. Haematologica. 2005; 90: 421–3
   Google Scholar
• Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, et al. Factor VII polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscl Thromb Vasc Biol. 1996; 16: 72–6
   PubMed Web of Science ®Google Scholar
• Pollak ES, Hung HL, Godin W, Overton GC, High KA. Functional characterization of the human factor VII 5′-flanking region. J Biol Chem. 1996; 19: 1738–47
   Google Scholar
• Meade TW, Mellows S, Brozovic M, Miller GH, Chakrabarti RR, North WR, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986; 2: 533–7
   PubMed Web of Science ®Google Scholar
• Mariani G, Lo Coco L, Bernardi F, Pinotti M. Molecular and clinical aspects of factor VII deficiency. Blood Coagul Fibrinolysis. 1998; 9: S83–8
   Google Scholar
• Miller CH, De Staercke C, Benson J, Hooper WC, Dilley A, Evatt BL, et al. Elevated factor VII as a risk factor for recurrent fetal loss Relationship to factor VII gene polymorphisms. Thromb Haemost. 2005; 93: 1089–94
   Google Scholar
• Rubattu S, Di Angelantonio E, Nitsch D, Gigante B, Zanda B, Stanzione R, et al. Polymorphisms in prothrombombotic genes and their impact on ischemic stroke in a Sardinian population. Thromb Haemost. 2005; 93: 1095–100
   PubMedGoogle Scholar
• Funk M, Endler G, Lalouscheck W, Hsieh K, Schillinger M, Lang W, et al. Factor VII gene haplotypes and risk to ischemic stroke. Clin Chem. 2006; 52: 1190–2
   PubMed Web of Science ®Google Scholar
• Bray PF. Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol. 2000; 7: 284–9
   Google Scholar
• Nikolopoulos GK, Tsantes AE, Bagos PG, Travlou A, Vaiopoulos G. Integrin, alpha 2 gene C807T polymorphism and risk of ischemic stroke: a meta-analysis. Thromb Res. 2007; 119: 501–10
   PubMed Web of Science ®Google Scholar
• Iniesta JA, Corral J, González-Conejero R, Piqueras C, Vicente V. Polymorphisms of platelet adhesive receptors: do they play a role in primary intracerebral hemorrhage?. Cerebrovasc Dis. 2003; 15: 51–5
   PubMed Web of Science ®Google Scholar
• Lip GYH. The prothrombotic state in atrial fibrillation: the atrium, the endothelium,.. and tissue factor?. Thromb Res. 2003; 111: 133–5
   PubMed Web of Science ®Google Scholar
• Nemerson Y. Tissue factor: then and now. Thromb Haemost. 1997; 74: 180–4
   Google Scholar
• Conway DSG, Pearce LA, Chin BSP, Hart RG, Lip GY. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation. 2003; 107: 3141–5
   PubMed Web of Science ®Google Scholar
• Lip GY, Lane D, Van Walraven C, Hart RG. Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation. Stroke. 2006; 37: 2294–300
   PubMed Web of Science ®Google Scholar